Search peptides, terms, sources/
Glossary

Agonist

A substance that binds to a specific receptor in the body and activates it, triggering the response that receptor normally produces. Many peptides described in this database are studied as “receptor agonists” because their reported effects, whether on appetite, growth hormone release or another pathway, depend on switching a receptor on rather than blocking it. Describing a peptide as an agonist for a given receptor explains part of how it is thought to work; it says nothing on its own about that peptide’s safety, UK legal status or how strong the supporting evidence actually is.

Peptides where this matters

  • Semaglutide

    GLP-1 receptor agonist studied in type 2 diabetes, weight management and cardiovascular outcomes. UK prescription-only medicine; studied in large randomised trials.

    Metabolic and incretinHuman trialsEvidence reviewed
    StrongLicensed UK medicine
  • Tirzepatide

    Dual GIP and GLP-1 receptor agonist studied in type 2 diabetes and weight management. UK prescription-only medicine; studied in large randomised trials.

    Metabolic and incretinHuman trialsEvidence reviewed
    StrongLicensed UK medicine
  • KisspeptinMetastin

    Natural reproductive hormone studied in UK trials for low sexual desire and IVF egg maturation. No UK marketing authorisation identified.

    Hormonal signallingHuman trialsEvidence reviewed
    LimitedNot licensed in the UK
  • Melanotan IIMT-II

    Synthetic melanocortin receptor agonist studied for skin tanning. Not licensed in the UK; human evidence is a three-volunteer pilot plus case reports.

    MelanocortinHuman trialsEvidence reviewed
    LimitedNot licensed in the UK

All glossary terms

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.